Elevance Health stock pre-market at EUR 367.15

Published on 10/12/2026 at 08:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health stock is at EUR 367.15 pre-market at Lang & Schwarz on October 12, 2026. Third-quarter results are scheduled for October 21.

Key points in brief

Elevance Health stock is at EUR 367.15 pre-market at Lang & Schwarz on October 12, 2026.
Third-quarter 2026 results are scheduled for October 21, 2026.
Management is scheduled to discuss the results at 8:30 a.m. EDT.

Modernes Krankenhaus-Campus mit Glasfassade und Patienten im Eingangsbereich — Elevance Health Krankenversicherungs-Campus US2855211023 zeigt modernen Gebäudeeingang mit weitläufiger Grünanlage unter blauem Himmel, Illustration mit AI erstellt.

At 8:44 a.m. CEST on October 12, 2026, Elevance Health stock was at EUR 367.15 in pre-market trading at Lang & Schwarz.

What matters today

Elevance Health is scheduled to release third-quarter 2026 financial results on October 21, 2026. A round-number reference level is EUR 400.00. Management is scheduled to discuss the results at 8:30 a.m. EDT on October 21, 2026.

Upcoming results date

In a company press release dated October 5, 2026, Elevance Health said it will publish its third-quarter financial results at 6:00 a.m. EDT on October 21. The company said management will review the results and its outlook during a conference call at 8:30 a.m. EDT, with a webcast available through its investor site.